A judge has rejected Samsung Bioepis’ bid to discover research and development documents from Pfizer as it seeks to invalidate the drug giant’s patent for its blockbuster autoimmune drug Enbrel, agreeing with Pfizer that it may be “no more than an exercise in fishing”.
Medibank failed to put in place baseline security measures, including multi-factor authentication, to safeguard sensitive information from a hacker in 2022, who stole an IT contractor’s credentials and logged in to the health insurer’s private network three months before the company learned its data was compromised, the OAIC says.
Elanco Australasia has lost its bid to appeal a finding by IP Australia that a patent acquired from Bayer covering a lice treatment for livestock lacked an inventive step.
The ACCC has flagged competition concerns about drug supplier Sigma Healthcare’s proposed $8.8 billion reverse merger with Chemist Warehouse, saying the tie-up could harm independent pharmacies and lessen competition in pharmacy retail.
After an 18-month investigation, the Office of the Australian Information Commissioner has lodged civil penalty proceedings against Medibank over its October 2022 data breach, accusing the health insurer of breaching the Privacy Act.
Drug giant Pfizer has blasted Samsung Bioepis’ âfishing expeditionâ in its suit alleging infringement of the patent for its blockbuster arthritis drug Enbrel, telling the court the Korean biotech should not be allowed to dig for new grounds of invalidity. Â
A judge has upheld Neurim Pharmaceuticalâs claim for additional damages against two generic drug companies found to have infringed its patent for insomnia drug Circadin, despite the company’s failure to comply with an earlier ruling.
Otsuka Pharmaceutical has hit back at suit filed by Indian generics company Sun Pharma seeking to invalidate its patent for blockbuster antipsychotic Abilify, filing a cross-claim seeking to restrain Sun Pharma from infringing the patent with a generic version of the drug.
Drug giant Glaxo has succeeded in extending the term for a patent for a drug that treats chronic obstructive pulmonary disease and asthma, with a delegate rejecting arguments from law firm Banki Haddock Fiora that the application was incorrectly based on a patent that was no longer valid because of amendments.
Medicinal cannabis company Vitura Health has won its bid for orders restricting the access of a software partner to its IT systems after an alleged hack.